ISNCA/I Gene Methylation in Parkinson’s Disease and Multiple System Atrophy

• Published in: Epigenomes Vol. 7; no. 1
• Main Authors: Fedotova, Ekaterina Yu, Iakovenko, Elena V, Abramycheva, Natalia Yu, Illarioshkin, Sergey N
• Format: Journal Article
• Language: English
• Published: MDPI AG 01-02-2023
• Subjects: Analysis; Atrophy; Epigenetic inheritance; Genetic aspects; Methylation; Parkinson's disease; Russia
• ISSN: 2075-4655; 2075-4655
• DOI: 10.3390/epigenomes7010005

In recent years, epigenetic mechanisms have been implicated in the development of multifactorial diseases including neurodegenerative disorders. In Parkinson’s disease (PD), as a synucleinopathy, most studies focused on DNA methylation of SNCA gene coding alpha-synuclein but obtained results were rather contradictory. In another neurodegenerative synucleinopathy, multiple system atrophy (MSA), very few studies investigated the epigenetic regulation. This study included patients with PD (n = 82), patients with MSA (n = 24), and a control group (n = 50). In three groups, methylation levels of CpG and non-CpG sites in regulatory regions of the SNCA gene were analyzed. We revealed hypomethylation of CpG sites in the SNCA intron 1 in PD and hypermethylation of predominantly non-CpG sites in the SNCA promoter region in MSA. In PD patients, hypomethylation in the intron 1 was associated with earlier age at the disease onset. In MSA patients, hypermethylation in the promotor was associated with shorter disease duration (before examination). These results showed different patterns of the epigenetic regulation in two synucleinopathies—PD and MSA.